2invest AG
Heidelberg2invest-ag.com
Overview
2invest AG is a Germany-based publicly traded investment company that acquires, holds, manages, and sells investments in corporations and partnerships, with a focus on the biotechnology, life science, and IT sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Leucid Bio | Feb 2025 | Series A Extension | Lead |
| NeoPhore | Jan 2023 | Series B Extension | Co-investor |
| Heqet Therapeutics | Mar 2022 | Series A | Lead |
| Kither Biotech | Mar 2022 | Series B | Lead |
| Leucid Bio | Oct 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
